Search Results - "Olsnes, Astrid Marta"
-
1
Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells
Published in Haematologica (Roma) (01-03-2007)“…From the Division for Hematology, Department of Medicine, Haukeland University Hospital and The University of Bergen, Bergen, Norway (OB, AR, AMartO, BTG);…”
Get full text
Journal Article -
2
Thrombosis and thrombocytopenia after HPV vaccination
Published in Journal of thrombosis and haemostasis (01-03-2022)“…Background Vaccine‐induced immune thrombotic thrombocytopenia (VITT) has so far only been reported after adenovirus vector severe acute respiratory syndrome…”
Get full text
Journal Article -
3
Thrombosis and thrombocytopenia after HPV vaccination
Published in Journal of thrombosis and haemostasis (2021)“…Background Vaccine-induced immune thrombotic thrombocytopenia (VITT) has so far only been reported after adenovirus vector severe acute respiratory syndrome…”
Get full text
Journal Article -
4
The protein kinase C agonist PEP005 increases NF‐κB expression, induces differentiation and increases constitutive chemokine release by primary acute myeloid leukaemia cells
Published in British journal of haematology (01-06-2009)“…Summary Acute myeloid leukaemia (AML) cells show constitutive release of several chemokines that occurs in three major clusters: (I) chemokine (C‐C motif)…”
Get full text
Journal Article -
5
T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): local release by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC)
Published in Cancer Immunology, Immunotherapy (01-07-2006)“…T cell targeting immunotherapy is now considered in acute myelogenous leukemia (AML), and local recruitment of antileukemic T cells to the AML microcompartment…”
Get full text
Journal Article -
6
In vitro induction of a dendritic cell phenotype in primary human acute myelogenous leukemia (AML) blasts alters the chemokine release profile and increases the levels of T cell chemotactic CCL17 and CCL22
Published in Journal of interferon & cytokine research (01-05-2008)“…Immunotherapy is now considered in acute myelogenous leukemia (AML). A dendritic cell (DC) phenotype can be induced in primary human AML cells by in vitro…”
Get more information
Journal Article -
7
Circulating T cells derived from acute leukemia patients with severe therapy-induced cytopenia express a wide range of chemokine receptors
Published in Hematology (Luxembourg) (01-12-2008)“…Normal T cells can mediate antileukemic reactivity after allogeneic stem cell transplantation and T cell targeting immunotherapy is now considered for patients…”
Get more information
Journal Article -
8
Nuclear factor-kappaB signaling: a contributor in leukemogenesis and a target for pharmacological intervention in human acute myelogenous leukemia
Published in Critical reviews in oncogenesis (2009)“…Acute myeloid leukemia (AML) is an aggressive malignancy with only 40%-50% long-term survival even for younger patients who can receive the most aggressive…”
Get more information
Journal Article -
9
The protein kinase C agonist PEP005 increases NF-kappaB expression, induces differentiation and increases constitutive chemokine release by primary acute myeloid leukaemia cells
Published in British journal of haematology (01-06-2009)“…Acute myeloid leukaemia (AML) cells show constitutive release of several chemokines that occurs in three major clusters: (I) chemokine (C-C motif) ligand…”
Get full text
Journal Article -
10